The mechanisms of IL-17A on promoting tumor metastasis

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86. doi: 10.1002/ijc.29210. PubMed PMID: 25220842.
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog 2013;18(1,2):43–73. PubMed PMID: 23237552; PubMed Central PMCID: PMCPMC3597235.
   PubMedGoogle Scholar
• Zhang Y, Fang N, You J, et al. [Advances in the relationship between tumor cell metabolism and tumor metastasis]. Zhongguo Fei Ai Za Zhi 2014;17(11):812–818. doi: 10.3779/j.issn.1009-3419.2014.11.07. PubMed PMID: 25404272.
   PubMedGoogle Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013;19(11):1423–1437. doi: 10.1038/nm.3394. PubMed PMID: 24202395; PubMed Central PMCID: PMCPMC3954707.
   PubMed Web of Science ®Google Scholar
• McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol 2014;16(8):717–727. doi: 10.1038/ncb3015. PubMed PMID: 25082194.
   PubMed Web of Science ®Google Scholar
• Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009;9(8):556–567. doi: 10.1038/nri2586. PubMed PMID: 19575028; PubMed Central PMCID: PMCPMC2821718.
   PubMed Web of Science ®Google Scholar
• Moseley TA, Haudenschild DR, Rose L, et al. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14(2):155–174. PubMed PMID: 12651226.
   PubMed Web of Science ®Google Scholar
• Oh H, Ghosh S. NF-kappaB: roles and regulation in different CD4(+) T-cell subsets. Immunol Rev 2013;252(1):41–51. doi: 10.1111/imr.12033. PubMed PMID: 23405894; PubMed Central PMCID: PMCPMC3576882.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang D, Han Q, et al. Role of distinct CD4 T helper subset in pathogenesis of oral lichen planus. J Oral Pathol Med 2015. doi: 10.1111/jop.12405. PubMed PMID: 26693958.
   PubMed Web of Science ®Google Scholar
• Kurebayashi Y, Nagai S, Ikejiri A, et al. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells. Genes Cells 2013;18(4):247–265. doi: 10.1111/gtc.12039. PubMed PMID: 23383714 ; PubMed Central PMCID: PMCPMC3657121.
   PubMed Web of Science ®Google Scholar
• Lyadova IV, Panteleev AV. Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers. Mediators Inflamm 2015;2015:854507. doi: 10.1155/2015/854507. PubMed PMID: 26640327; PubMed Central PMCID: PMCPMC4657112.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, et al. Induction and effector functions of T(H)17 cells. Nature 2008;453(7198):1051–1057. doi: 10.1038/nature07036. PubMed PMID: 18563156.
   PubMed Web of Science ®Google Scholar
• Pollinger B, Junt T, Metzler B, et al. Th17 cells, not IL-17+ gammadelta T cells, drive arthritic bone destruction in mice and humans. J Immunol 2011;186(4):2602–2612. doi: 10.4049/jimmunol.1003370. PubMed PMID: 21217016.
   PubMed Web of Science ®Google Scholar
• Stark MA, Huo Y, Burcin TL, et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005;22(3):285–294. doi: 10.1016/j.immuni.2005.01.011. PubMed PMID: 15780986.
   PubMed Web of Science ®Google Scholar
• Buonocore S, Ahern PP, Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010;464(7293):1371–1375. doi: 10.1038/nature08949. PubMed PMID: 20393462; PubMed Central PMCID: PMCPMC3796764.
   PubMed Web of Science ®Google Scholar
• Michel ML, Mendes-da-Cruz D, Keller AC, et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci U S A 2008;105(50):19845–19850. doi: 10.1073/pnas.0806472105. PubMed PMID: 19057011; PubMed Central PMCID: PMCPMC2604995.
   PubMed Web of Science ®Google Scholar
• Ciric B, El-behi M, Cabrera R, et al. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol 2009;182(9):5296–5305. doi: 10.4049/jimmunol.0900036. PubMed PMID: 19380776.
   PubMed Web of Science ®Google Scholar
• O'Brien RL, Roark CL, Born WK. IL-17-producing gammadelta T cells. Eur J Immunol 2009;39(3):662–666. doi: 10.1002/eji.200839120. PubMed PMID: 19283718; PubMed Central PMCID: PMCPMC2698711.
   PubMed Web of Science ®Google Scholar
• Chowdhury AC, Chaurasia S, Mishra SK, et al. IL-17 and IFN-gamma producing NK and gammadelta-T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis. Clin Immunol 2017;S1521–6616(16):30294–7. doi: 10.1016/j.clim.2017.03.016. PubMed PMID: 28390966.
   PubMedGoogle Scholar
• Coffelt SB, Kersten K, Doornebal CW, Weiden J, et al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015;522(7556):345–348. doi: 10.1038/nature14282. PubMed PMID: 25822788; PubMed Central PMCID: PMCPMC4475637.
   PubMed Web of Science ®Google Scholar
• Li TJ, Jiang YM, Hu YF, et al. Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer. Clin Cancer Res 2017;23(6):1575–1585. doi: 10.1158/1078-0432.CCR-16-0617. PubMed PMID: 27620275.
   PubMed Web of Science ®Google Scholar
• Siew LQC, Wu SY, Ying S, et al. Cigarette smoking increases bronchial mucosal IL-17A expression in asthmatics, which acts in concert with environmental aeroallergens to engender neutrophilic inflammation. Clin Exp Allergy 2017;47(6):740–750. doi: 10.1111/cea.12907. PubMed PMID: 28211191.
   PubMed Web of Science ®Google Scholar
• Yu JJ, Gaffen SL. Interleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 2008;13:170–177. PubMed PMID: 17981535.
   PubMed Web of Science ®Google Scholar
• Pan B, Shen J, Cao J, et al. Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Sci Rep 2015;5:16053. doi: 10.1038/srep16053. PubMed PMID: 26524953; PubMed Central PMCID: PMCPMC4630609.
   PubMed Web of Science ®Google Scholar
• Peng SF, Wang SJ, Chen JG, et al. [Detection and significance of transcription factors and cytokines of Th17/Treg cells in peripheral blood in the gastric cancer patients]. Zhonghua Zhong Liu Za Zhi 2010;32(3):185–189. PubMed PMID: 20450585.
   PubMedGoogle Scholar
• He S, Fei M, Wu Y, et al. Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients. Int J Mol Sci 2011;12(11):7424–7437. doi: 10.3390/ijms12117424. PubMed PMID: 22174607; PubMed Central PMCID: PMCPMC3233413.
   PubMed Web of Science ®Google Scholar
• Meng XY, Zhou CH, Ma J, et al. Expression of interleukin-17 and its clinical significance in gastric cancer patients. Med Oncol 2012;29(5):3024–3028. doi: 10.1007/s12032-012-0273-1. PubMed PMID: 22744708.
   PubMed Web of Science ®Google Scholar
• He D, Li H, Yusuf N, et al. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol 2010;184(5):2281–2288. doi: 10.4049/jimmunol.0902574. PubMed PMID: 20118280; PubMed Central PMCID: PMCPMC3179912.
   PubMed Web of Science ®Google Scholar
• Inozume T, Hanada K, Wang QJ, et al. IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells. J Immunother 2009;32(2):109–117. doi: 10.1097/CJI.0b013e31819302da. PubMed PMID: 19238009.
   PubMed Web of Science ®Google Scholar
• Kim G, Khanal P, Lim SC, et al. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity. Carcinogenesis 2013;34(2):341–350. doi: 10.1093/carcin/bgs342. PubMed PMID: 23125217.
   PubMed Web of Science ®Google Scholar
• Cochaud S, Giustiniani J, Thomas C, et al. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. Scientific Reports 2013;3:3456. doi: 10.1038/srep03456. PubMed PMID: 24316750; PubMed Central PMCID: PMCPMC3856404.
   PubMed Web of Science ®Google Scholar
• Fabre J, Giustiniani J, Garbar C, et al. Targeting the tumor microenvironment: The protumor effects of IL-17 related to cancer type. Int J Mol Sci 2016;17(9):1433. doi: 10.3390/ijms17091433. PubMed PMID: 27589729; PubMed Central PMCID: PMCPMC5037712.
   PubMed Web of Science ®Google Scholar
• Iida T, Iwahashi M, Katsuda M, et al. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 2011;25(5):1271–1277. doi: 10.3892/or.2011.1201. PubMed PMID: 21369705.
   PubMed Web of Science ®Google Scholar
• Gu FM, Li QL, Gao Q, et al. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer 2011;10:150. doi: 10.1186/1476-4598-10-150. PubMed PMID: 22171994; PubMed Central PMCID: PMCPMC3310750.
   PubMed Web of Science ®Google Scholar
• Zhong J, Chen Y, Wang LJ. Emerging molecular basis of hematogenous metastasis in gastric cancer. World J Gastroenterol 2016;22(8):2434–2440. doi: 10.3748/wjg.v22.i8.2434. PubMed PMID: 26937132; PubMed Central PMCID: PMCPMC4768190.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1(1):27–31. PubMed PMID: 7584949.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Dobashi Y, Hatakeyama Y, et al. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-beta phosphorylation, and microvessel density in gastric cancer. BMC Cancer 2010;10:659. doi: 10.1186/1471-2407-10-659. PubMed PMID: 21118571; PubMed Central PMCID: PMCPMC3009982.
   PubMed Web of Science ®Google Scholar
• Choi JH, Ahn MJ, Park CK, et al. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray. APMIS 2006;114(9):619–625. doi: 10.1111/j.1600-0463.2006.apm_401.x. PubMed PMID: 16948814.
   PubMed Web of Science ®Google Scholar
• Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003;101(7):2620–2627. doi: 10.1182/blood-2002-05-1461. PubMed PMID: 12411307.
   PubMed Web of Science ®Google Scholar
• Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005;175(9):6177–6189. PubMed PMID: 16237115.
   PubMed Web of Science ®Google Scholar
• Iordache S, Saftoiu A, Georgescu CV, et al. Vascular endothelial growth factor expression and microvessel density–two useful tools for the assessment of prognosis and survival in gastric cancer patients. J Gastrointestin Liver Dis 2010;19(2):135–139. PubMed PMID: 20593045.
   PubMed Web of Science ®Google Scholar
• Yan J, Chen W, Ma Y, et al. Expression of vascular endothelial growth factor in liver tissues of hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2000;8(3):150–152. PubMed PMID: 10880162.
   PubMedGoogle Scholar
• Xue JT, Wu J, Meng L, et al. Expression of VEGF(121) in gastric carcinoma MGC803 cell line. World J Gastroenterol 2000;6(2):281–283. PubMed PMID: 11819577; PubMed Central PMCID: PMCPMC4723505.
   PubMed Web of Science ®Google Scholar
• Huang QB, Ma X, Li HZ, et al. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis. Oncotarget 2014;5(10):3066–3075. doi: 10.18632/oncotarget.1827. PubMed PMID: 24931473; PubMed Central PMCID: PMCPMC4102792.
   PubMed Web of Science ®Google Scholar
• Liu J, Duan Y, Cheng X, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011;407(2):348–354. doi: 10.1016/j.bbrc.2011.03.021. PubMed PMID: 21396350.
   PubMed Web of Science ®Google Scholar
• Zhang JP, Yan J, Xu J, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 2009;50(5):980–989. doi: 10.1016/j.jhep.2008.12.033. PubMed PMID: 19329213.
   PubMed Web of Science ®Google Scholar
• Niu G, Bowman T, Huang M, et al. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene 2002;21(46):7001–7010. doi: 10.1038/sj.onc.1205859. PubMed PMID: 12370822.
   PubMed Web of Science ®Google Scholar
• Xie K, Wei D, Shi Q, et al. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine Growth Factor Rev 2004;15(5):297–324. doi: 10.1016/j.cytogfr.2004.04.003. PubMed PMID: 15450248.
   PubMed Web of Science ®Google Scholar
• Yu CL, Meyer DJ, Campbell GS, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995;269(5220):81–83. PubMed PMID: 7541555.
   PubMed Web of Science ®Google Scholar
• Roskoski R, Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 2007;62(3):179–213. doi: 10.1016/j.critrevonc.2007.01.006. PubMed PMID: 17324579.
   PubMed Web of Science ®Google Scholar
• Gong W, Wang L, Yao JC, et al. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res 2005;11(4):1386–1393. doi: 10.1158/1078-0432.CCR-04-0487. PubMed PMID: 15746037.
   PubMed Web of Science ®Google Scholar
• Kanda N, Seno H, Konda Y, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004;23(28):4921–4929. doi: 10.1038/sj.onc.1207606. PubMed PMID: 15077160.
   PubMed Web of Science ®Google Scholar
• Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Tech 2001;55(2):92–99. doi: 10.1002/jemt.1160. PubMed PMID: 11596154.
   PubMed Web of Science ®Google Scholar
• Akagi K, Ikeda Y, Miyazaki M, et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000;83(7):887–891. doi: 10.1054/bjoc.2000.1396. PubMed PMID: 10970690; PubMed Central PMCID: PMCPMC2374684.
   PubMed Web of Science ®Google Scholar
• Bunone G, Vigneri P, Mariani L, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999;155(6):1967–1976. doi: 10.1016/S0002-9440(10)65515-0. PubMed PMID: 10595926; PubMed Central PMCID: PMCPMC1866941.
   PubMed Web of Science ®Google Scholar
• Fellmer PT, Sato K, Tanaka R, et al. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery 1999;126(6):1056–1061; discussion 61–2. PubMed PMID: 10598188.
   PubMed Web of Science ®Google Scholar
• Kurebayashi J, Otsuki T, Kunisue H, et al. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res 1999;90(9):977–981. PubMed PMID: 10551327.
   PubMedGoogle Scholar
• Ohta Y, Nozawa H, Tanaka Y, et al. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2000;119(4 Pt 1):804–813. doi: 10.1016/S0022-5223(00)70017-1. PubMed PMID: 10733773.
   PubMed Web of Science ®Google Scholar
• Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999;80(1,2):309–313. doi: 10.1038/sj.bjc.6690356. PubMed PMID: 10390013; PubMed Central PMCID: PMCPMC2362987.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999;5(7):1823–1829. PubMed PMID: 10430087.
   PubMed Web of Science ®Google Scholar
• Varricchi G, Granata F, Loffredo S, et al. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol 2015;73(1):144–153. doi: 10.1016/j.jaad.2015.03.041. PubMed PMID: 25922287.
   PubMed Web of Science ®Google Scholar
• Renyi-Vamos F, Tovari J, Fillinger J, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005;11(20):7344–7353. doi: 10.1158/1078-0432.CCR-05-1077. PubMed PMID: 16243806.
   PubMed Web of Science ®Google Scholar
• Chen F, Takenaka K, Ogawa E, et al. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer. Clin Cancer Res 2004;10(24):8548–8553. doi: 10.1158/1078-0432.CCR-04-0950. PubMed PMID: 15623638.
   PubMed Web of Science ®Google Scholar
• Mantovani A. Cancer: Inflaming metastasis. Nature 2009;457(7225):36–37. doi: 10.1038/457036b. PubMed PMID: 19122629.
   PubMed Web of Science ®Google Scholar
• He D, Wu L, Kim HK, et al. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 2006;177(10):6852–6858. PubMed PMID: 17082599; PubMed Central PMCID: PMCPMC3179908.
   PubMed Web of Science ®Google Scholar
• Ferretti S, Bonneau O, Dubois GR, et al. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003;170(4):2106–2112. PubMed PMID: 12574382.
   PubMed Web of Science ®Google Scholar
• Ito Y, Usui T, Kobayashi S, et al. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum 2009;60(8):2294–2303. doi: 10.1002/art.24687. PubMed PMID: 19644886.
   PubMed Web of Science ®Google Scholar
• Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009;10(1):66–74. doi: 10.1038/ni.1668. PubMed PMID: 19029905.
   PubMed Web of Science ®Google Scholar
• Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108(3):430–438. doi: 10.1067/mai.2001.117929. PubMed PMID: 11544464.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Desta T, Fenton M, et al. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun 2005;73(2):935–943. doi: 10.1128/IAI.73.2.935-943.2005. PubMed PMID: 15664935; PubMed Central PMCID: PMCPMC547047.
   PubMed Web of Science ®Google Scholar
• Su X, Ye J, Hsueh EC et al. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 2010;184(3):1630–1641. doi: 10.4049/jimmunol.0902813. PubMed PMID: 20026736.
   PubMed Web of Science ®Google Scholar
• Zhu X, Mulcahy LA, Mohammed RA, et al. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 2008;10(6):R95. doi: 10.1186/bcr2195. PubMed PMID: 19014637; PubMed Central PMCID: PMCPMC2656888.
   PubMed Web of Science ®Google Scholar
• Zhang B, Rong G, Wei H, et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 2008;374(3):533–537. doi: 10.1016/j.bbrc.2008.07.060. PubMed PMID: 18655770.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140(6):883–899. doi: 10.1016/j.cell.2010.01.025. PubMed PMID: 20303878; PubMed Central PMCID: PMCPMC2866629.
   PubMed Web of Science ®Google Scholar
• Chen X, Wan J, Liu J, et al. Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 2010;69(3):348–354. doi: 10.1016/j.lungcan.2009.11.013. PubMed PMID: 20022135.
   PubMed Web of Science ®Google Scholar
• Chen X, Xie Q, Cheng X, et al. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells. Cancer Sci 2010;101(11):2384–2390. doi: 10.1111/j.1349-7006.2010.01684.x. PubMed PMID: 20825419.
   PubMed Web of Science ®Google Scholar
• Li C, Zhao Y, Zhang W et al. Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112(1):81–19. doi: 10.1016/j.tripleo.2010.11.032. PubMed PMID: 21458322.
   PubMed Web of Science ®Google Scholar
• Gu FM, Gao Q, Shi GM, et al. Intratumoral IL-17(+) cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2012;19(8):2506–2514. doi: 10.1245/s10434-012-2268-8. PubMed PMID: 22411204.
   PubMed Web of Science ®Google Scholar
• Li Q, Li Q, Chen J, et al. Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep 2013;30(3):1215–1222. doi: 10.3892/or.2013.2570. PubMed PMID: 23807713.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hou F, Liu X, et al. Tc17 cells in patients with uterine cervical cancer. PLoS One 2014;9(2):e86812. doi: 10.1371/journal.pone.0086812. PubMed PMID: 24523865; PubMed Central PMCID: PMCPMC3921122.
   PubMed Web of Science ®Google Scholar
• Jiang YX, Li PA, Yang SW, et al. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients. Int J Clin Exp Pathol 2015;8(6):7002–7008. PubMed PMID: 26261590; PubMed Central PMCID: PMCPMC4525924.
   PubMed Web of Science ®Google Scholar
• Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011;147(5):992–1009. doi: 10.1016/j.cell.2011.11.016. PubMed PMID: 22118458.
   PubMed Web of Science ®Google Scholar
• Li J, Lau GK, Chen L, et al. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 2011;6(7):e21816. doi: 10.1371/journal.pone.0021816. PubMed PMID: 21760911; PubMed Central PMCID: PMCPMC3131399.
   PubMed Web of Science ®Google Scholar
• Wang JB. [Establishment and some characteristics of a hepatoma cell line (QGY-7703) (author's transl)]. Zhonghua Zhong Liu Za Zhi 1981;3(4):241–244. PubMed PMID: 6280941.
   PubMedGoogle Scholar
• Li Y, Tang ZY, Ye SL, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001;7(5):630–636. PubMed PMID: 11819844; PubMed Central PMCID: PMCPMC4695564.
   PubMed Web of Science ®Google Scholar
• Jiang YX, Yang SW, Li PA, et al. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms. Oncogene 2017;36(9):1256–1264. doi: 10.1038/onc.2016.291. PubMed PMID: 27524415; PubMed Central PMCID: PMCPMC5340802.
   PubMed Web of Science ®Google Scholar
• Sun Y, Pan J, Mao S, et al. IL-17/miR-192/IL-17Rs regulatory feedback loop facilitates multiple myeloma progression. PloS one 2014;9(12):e114647. doi: 10.1371/journal.pone.0114647. PubMed PMID: 25489847; PubMed Central PMCID: PMCPMC4260882.
   PubMed Web of Science ®Google Scholar
• Gu K, Li MM, Shen J, et al. Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-kappaB/ZEB1 signal pathway. Am J Cancer Res 2015;5(3):1169–1179. PubMed PMID: 26045995; PubMed Central PMCID: PMCPMC4449444.
   PubMed Web of Science ®Google Scholar
• Wang L, Ma R, Kang Z, et al. Effect of IL-17A on the migration and invasion of NPC cells and related mechanisms. PloS one 2014;9(9):e108060. doi: 10.1371/journal.pone.0108060. PubMed PMID: 25244643; PubMed Central PMCID: PMCPMC4171532.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Liu S, Parajuli KR, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene 2017;36(5):687–699. doi: 10.1038/onc.2016.240. PubMed PMID: 27375020; PubMed Central PMCID: PMCPMC5213194.
   PubMed Web of Science ®Google Scholar
• Lifschitz-Mercer B, Czernobilsky B, Dgani R, et al. Immunocytochemical study of an endometrial diffuse clear cell stromal sarcoma and other endometrial stromal sarcomas. Cancer 1987;59(8):1494–1499. PubMed PMID: 2434209.
   PubMed Web of Science ®Google Scholar
• Raz A, Ben-Ze'ev A. Cell-contact and -architecture of malignant cells and their relationship to metastasis. Cancer Metastasis Rev 1987;6(1):3–21. PubMed PMID: 3297370.
   PubMed Web of Science ®Google Scholar
• Doreau A, Belot A, Bastid J, et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009;10(7):778–785. doi: 10.1038/ni.1741. PubMed PMID: 19483719.
   PubMed Web of Science ®Google Scholar
• Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 1998;273(42):27467–27473. PubMed PMID: 9765276.
   PubMed Web of Science ®Google Scholar
• Bond M, Fabunmi RP, Baker AH, et al. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 1998;435(1):29–34. PubMed PMID: 9755853.
   PubMed Web of Science ®Google Scholar
• Littlepage LE, Sternlicht MD, Rougier N, et al. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 2010;70(6):2224–2234. doi: 10.1158/0008-5472.CAN-09-3515. PubMed PMID: 20215503; PubMed Central PMCID: PMCPMC2840052.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2(3):161–174. doi: 10.1038/nrc745. PubMed PMID: 11990853.
   PubMed Web of Science ®Google Scholar
• Yang P, Yuan W, He J, et al. Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis. Hepatol Res 2009;39(12):1169–1177. doi: 10.1111/j.1872-034X.2009.00563.x. PubMed PMID: 19788698.
   PubMed Web of Science ®Google Scholar
• Romanic AM, White RF, Arleth AJ et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998;29(5):1020–1030. PubMed PMID: 9596253.
   PubMed Web of Science ®Google Scholar
• Turner HE, Nagy Z, Esiri MM, et al. Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metab 2000;85(8):2931–2935. doi: 10.1210/jcem.85.8.6754. PubMed PMID: 10946906.
   PubMed Web of Science ®Google Scholar
• Jovanovic DV, Martel-Pelletier J, Di Battista JA, et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum 2000;43(5):1134–1144. doi: 10.1002/1529-0131. PubMed PMID: 10817568.
   PubMed Web of Science ®Google Scholar
• Qiu L, He D, Fan X, et al. The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas. Pituitary 2011;14(3):266–275. doi: 10.1007/s11102-011-0292-5. PubMed PMID: 21279695.
   PubMed Web of Science ®Google Scholar
• Iida T, Iwahashi M, Katsuda M, et al. Prognostic significance of IL-17 mRNA expression in peritoneal lavage in gastric cancer patients who underwent curative resection. Oncol Rep 2014;31(2):605–612. doi: 10.3892/or.2013.2911. PubMed PMID: 24337702.
   PubMed Web of Science ®Google Scholar
• Yeung TL, Leung CS, Yip KP, et al. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol 2015;309(7):C444–C456. doi: 10.1152/ajpcell.00188.2015. PubMed PMID: 26224579; PubMed Central PMCID: PMCPMC4593771.
   PubMed Web of Science ®Google Scholar
• Koppe MJ, Nagtegaal ID, de Wilt JH, et al. Recent insights into the pathophysiology of omental metastases. J Surg Oncol 2014;110(6):670–675. doi: 10.1002/jso.23681. PubMed PMID: 24962271.
   PubMed Web of Science ®Google Scholar
• Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011;17(11):1498–1503. doi: 10.1038/nm.2492. PubMed PMID: 22037646; PubMed Central PMCID: PMCPMC4157349.
   PubMed Web of Science ®Google Scholar
• Manabe Y, Toda S, Miyazaki K, et al. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 2003;201(2):221–228. doi: 10.1002/path.1430. PubMed PMID: 14517839.
   PubMed Web of Science ®Google Scholar
• Tokuda Y, Satoh Y, Fujiyama C, et al. Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction. BJU Int. 2003;91(7):716–720. PubMed PMID: 12699491.
   PubMed Web of Science ®Google Scholar
• Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011;71(7):2455–2465. doi: 10.1158/0008-5472.CAN-10-3323. PubMed PMID: 21459803.
   PubMed Web of Science ®Google Scholar
• Wang L, Yi T, Kortylewski M, et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009;206(7):1457–1464. doi: 10.1084/jem.20090207. PubMed PMID: 19564351; PubMed Central PMCID: PMCPMC2715087.
   PubMed Web of Science ®Google Scholar
• Qu Y, Zhang Q, Ma S, et al. Interleukin-17A differentially induces inflammatory and metabolic gene expression in the adipose tissues of lean and obese mice. Int J Mol Sci 2016;17(4):522. doi: 10.3390/ijms17040522. PubMed PMID: 27070576; PubMed Central PMCID: PMCPMC4848978.
   PubMed Web of Science ®Google Scholar
• Seebauer CT, Brunner S, Glockzin G, et al. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells. Oncoimmunology 2016;5(12):e1242543. doi: 10.1080/2162402X.2016.1242543. PubMed PMID: 28439450; PubMed Central PMCID: PMCPMC5391678.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Wei S, Szeliga W, et al. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009;114(2):357–359. doi: 10.1182/blood-2008-09-177360. PubMed PMID: 19289853; PubMed Central PMCID: PMCPMC2714210.
   PubMed Web of Science ®Google Scholar
• Martin-Orozco N, Muranski P, Chung Y, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity2009;31(5):787–798. doi: 10.1016/j.immuni.2009.09.014. PubMed PMID: 19879162; PubMed Central PMCID: PMCPMC2787786.
   PubMed Web of Science ®Google Scholar